Despite warnings, antipsychotics for elderly on the rise

Physicians have not sufficiently heeded warnings about prescribing antipsychotic drugs for seniors with dementia, Canadian researchers suggest.

While safety warnings have slowed their use, too many dangers remain, according to Dr. Geoffrey Anderson, of the University of Toronto, and colleagues. They analyzed prescription data in Ontario and discovered antipsychotic drug use rose 20% from a month before the first of three federal warnings were issued until a five-year period ended in 2007. More than two-thirds of the study subjects were nursing home residents.

Health Canada, the country's national department of public health, issued warnings about three new atypical antipsychotic drugs between late 2002 and mid-2005. The drugs increase the risk of stroke and death in seniors with dementia, federal officials said. Studying findings were reported in the Canadian Medical Association Journal.

More in News

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in ...

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more ...

Long-term care providers should follow hospitals in adopting EHRs, government says ...

Healthcare providers have already exceeded the government's 2013 adoption goals for electronic health records, the Department of Health and Human Services announced Wednesday.

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.